Why the study?
Can physiological cardiac reserve be measured non-invasively and does it determine exercise capacity in humans?
Can physiological cardiac reserve be measured non-invasively and does it determine exercise capacity in humans?
Non-invasive estimation of physiological cardiac reserve using CO2 rebreathing correlates strongly with aerobic capacity and exercise duration, offering a potential tool to assess cardiac impairment in heart failure.
May support non-invasive cardiac reserve assessment in HF; leaves open validation for risk stratification or therapy guidance.
Objective To investigate whether physiological cardiac reserve can be measured in man without invasive procedures and whether it is a major determinant of exercise capacity. Design Development of method of measurement and an observational study. Setting A regional cardiothoracic centre. Subjects 70 subjects with a wide range of cardiac function, from heart failure patients to athletes. Methods Subjects underwent treadmill, symptom limited cardiopulmonary exercise tests to measure aerobic exercise capacity (represented by V˙ o 2 max) and cardiac reserve. Cardiac output was measured non-invasively using the C O 2 rebreathing technique. Results Cardiac power output (CPO max ) at peak exercise was found to be significantly related to aerobic capacity: CPO max (W) = 0.35 + 1.5V˙ o 2 max (l/min), r = 0.87, p < 0.001. It also correlated well with exercise duration ( r = 0.62, p < 0.001), suggesting that cardiac reserve is a major determinant of exercise capacity. In the study, cardiac reserve ranged from 0.27 to 5.65 W, indicating a 20-fold difference between the most impaired cardiac function and that of the fittest subject. Conclusions A non-invasive method of estimating physiological cardiac reserve was developed. The reserve was found to be a major determinant of exercise capacity in a population of normal subjects and patients with heart disease. This method may thus be used to provide a clearer definition of the extent of cardiac impairment in patients with heart failure.
No takes yet. Share an insight, caveat, or question.
Cooke et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: